16-1210793-G-A
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_021098.3(CACNA1H):c.4045G>A(p.Ala1349Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000675 in 1,600,820 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1349V) has been classified as Uncertain significance.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | NM_021098.3 | MANE Select | c.4045G>A | p.Ala1349Thr | missense | Exon 21 of 35 | NP_066921.2 | ||
| CACNA1H | NM_001005407.2 | c.4045G>A | p.Ala1349Thr | missense | Exon 21 of 34 | NP_001005407.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | TSL:1 MANE Select | c.4045G>A | p.Ala1349Thr | missense | Exon 21 of 35 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | TSL:1 | c.4045G>A | p.Ala1349Thr | missense | Exon 21 of 34 | ENSP00000454990.2 | ||
| CACNA1H | ENST00000711493.1 | c.4045G>A | p.Ala1349Thr | missense | Exon 21 of 34 | ENSP00000518778.1 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152246Hom.: 0 Cov.: 35 show subpopulations
GnomAD2 exomes AF: 0.000290 AC: 69AN: 237694 AF XY: 0.000268 show subpopulations
GnomAD4 exome AF: 0.0000642 AC: 93AN: 1448456Hom.: 1 Cov.: 39 AF XY: 0.0000652 AC XY: 47AN XY: 721102 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000984 AC: 15AN: 152364Hom.: 0 Cov.: 35 AF XY: 0.000134 AC XY: 10AN XY: 74510 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34098317, 37593999)
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at